# STARLiT (NCT06574880)

> STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06574880
- Phase: PHASE1, PHASE2
- Status: RECRUITING
- Sponsor: Angela Y. Jia, MD PhD
- Conditions: Malignant Neoplasm of Prostate; Locally Advanced Prostate Cancer
- Interventions: Lu-PSMA-617; 5-fraction Stereotactic Body Radiation Therapy (SBRT)
- Enrollment: 45
- Primary outcome: Phase I: Maximum tolerated dose (MTD) of Lu-PSMA-617
- Primary outcome: Phase II: Androgen deprivation therapy (ADT)-free survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=starlit-nct06574880